Form 4 for DXR DAXOR CORP
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-20 · accession 0001493152-26-012444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-24 | 2026-03-20 | DXR | Jefferies John | Chief Medical Off | P - Purchase | $0.00 | +5,941 | 21.3K | +39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Daxor Common Stock | 2026-03-20 | P | A | 2,285 | $0.00 | 23,557 | D | — | — | (F2) 2,285 shares granted vested on March 20, 2026 |
| 2 | Common | Daxor Common Stock | 2026-03-20 | P | A | 3,656 | $0.00 | 21,272 | D | — | — | (F1) 3,656 shares granted vest on March 20, 2029. |